Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Sponsor: Outlook Therapeutics, Inc.
Summary
This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.
Official title: A Clinical Effectiveness, Multicenter, Randomized, Double-masked, Controlled Study of the Efficacy and Safety of ONS-5010 in Subjects With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
228
Start Date
2019-06-25
Completion Date
2021-07-08
Last Updated
2026-08-03
Healthy Volunteers
No
Conditions
Interventions
bevacizumab
1.25 mg, intravitreal injection
ranibizumab
0.5mg, intravitreal injection
Locations (50)
Clinical Site
Tucson, Arizona, United States
Clinical Site
Arcadia, California, United States
Clinical Site
Beverly Hills, California, United States
Clinical Site
Campbell, California, United States
Clinical Site
Glendale, California, United States
Clinical Site
Laguna Hills, California, United States
Clinical Site
Long Beach, California, United States
Clinical Site
Mountain View, California, United States
Clinical Site
Oxnard, California, United States
Clinical Site
Palm Desert, California, United States
Clinical Site
Poway, California, United States
Clinical Site
Sacramento, California, United States
Clinical Site
Santa Maria, California, United States
Clinical Site
Tustin, California, United States
Clinical Site
Golden, Colorado, United States
Clinical Site
Hamden, Connecticut, United States
Clinical Site
Clearwater, Florida, United States
Clinical Site
Pinellas Park, Florida, United States
Clinical Site
Sarasota, Florida, United States
Clinical Site
Winter Haven, Florida, United States
Clinical Site
Augusta, Georgia, United States
Clinical Site
Marietta, Georgia, United States
Clinical Site
Downers Grove, Illinois, United States
Clinical Site
Lemont, Illinois, United States
Clinical Site
Springfield, Illinois, United States
Clinical Site
Indianapolis, Indiana, United States
Clinical Site
Hagerstown, Maryland, United States
Clinical Site
Edina, Minnesota, United States
Clinical Site
St Louis, Missouri, United States
Clinical Site
Bloomfield, New Jersey, United States
Clinical Site
Albuquerque, New Mexico, United States
Clinical Site
New York, New York, United States
Clinical Site
Chambersburg, Pennsylvania, United States
Clinical Site
Monroeville, Pennsylvania, United States
Clinical Site
Rapid City, South Dakota, United States
Clinical Site
Germantown, Tennessee, United States
Clinical Site
Abilene, Texas, United States
Clinical Site
Amarillo, Texas, United States
Clinical Site
Arlington, Texas, United States
Clinical Site
Dallas, Texas, United States
Clinical Site
Grapevine, Texas, United States
Clinical Site
Houston, Texas, United States
Clinical Site
McAllen, Texas, United States
Clinical Site
San Antonio, Texas, United States
Clinical Site
San Antonio, Texas, United States
Clinical Site
The Woodlands, Texas, United States
Clinical Site
Willow Park, Texas, United States
Clinical Site
Salt Lake City, Utah, United States
Clinical Site
Norfolk, Virginia, United States
Clinical Site
Madison, Wisconsin, United States